A Composite Assay for HER2-positive Early-stage Breast Cancer Management

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Composite Assay for HER2-positive Early-stage Breast Cancer Management	Breast Cancer Early Stage Breast Cancer (Stage 1-3); HER2	Recruiting	Not stated	2025-01-08		NCT06762977

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	62
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale	16
Ospedale Di Summa-Perrino	1

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale	Naples	Italy	1
Ospedale Di Summa-Perrino	Brindisi	Italy	1

Clinical trials